In humans, there is an increased expression of osteopontin in the urine in several kidney diseases: hypertensive nephropathy, renal carcinoma, membranous glomerulonephritis, IgA nephropathy, lupus nephritis and in mouse models of ADPKD. This evidence concerns the gene SPP1 and membranous glomerulonephritis.